The International Campaign to End War and Disease (IC2EWD) is a campaign advocating for a shift in public funding from military spending toward clinical trials. Its central proposal, the 1% Treaty, would redirect 1% of global military spending to expand publicly funded medical research and give more patients opportunities to participate in pragmatic trials.

IC2EWD argues that conventional clinical research is costly and slow, leaving many potential treatments untested and people with untreated diseases waiting for progress. It points to the Oxford RECOVERY trial as an example of pragmatic research conducted at far lower cost per patient than standard trials. The campaign highlights the large number of known safe compounds and possible drug-disease combinations that have yet to be studied, and presents increased trial capacity as a way to accelerate treatment discovery.

Through its website, IC2EWD explains its funding proposal, shares research figures and arguments about clinical-trial efficiency, and invites visitors to indicate how they would divide government funding between weapons and trials.